ambien
Minerva’s insomnia treatment beats Ambien in Phase 2b trial
June 25, 2019Manufacturing and Production MDD, Minerva Neurosciences, Placebo, ambien, insomnia, pharma, zolpidem
Massachusetts-based firm Minerva Neurosciences has announced that its sleeping pill seltorexant beat both Sanofi’s Ambien (zolpidem) and placebo in treating …
Ambien and other insomnia meds to be labelled with black box warnings after sleepwalking deaths
May 2, 2019Medical Communications, Research and Development FDA, ambien, black box warning, insomnia, sleeping pills, warning label
The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …
The July/August issue of Pharmafocus is now live!
July 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Elizabeth Holmes, NHS, Sanofi, Theranos, UK, ambien, manufacturing compliance, opdivo, patient recruitment, patient retention, pharma
The new July/August edition of Pharmafocus is now available to read online.
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
October 13, 2026
Tridem begins phase Ib trial of Parkinson’s disease vaccine
October 13, 2026
Trio become latest Symbiosis commercial additions
October 12, 2026
UK immunoglobulin supply faces growing pressure, report warns
October 12, 2026
